{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:12:15Z","timestamp":1769170335195,"version":"3.49.0"},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008329","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T17:38:39Z","timestamp":1596735519000},"page":"e0008329","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["The organization, weaknesses, and challenges of the control of thalidomide in Brazil: A review"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-7566","authenticated-orcid":true,"given":"Soraya Machado de","family":"Jesus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Santos","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana Nair","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"issue":"1","key":"pntd.0008329.ref001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S0102-311X1999000100011","article-title":"Talidomida no Brasil: vigil\u00e2ncia com responsabilidade compartilhada?.","volume":"15","author":"MA Oliveira","year":"1999","journal-title":"Cad. Sa\u00fade P\u00fablica"},{"issue":"5","key":"pntd.0008329.ref002","first-page":"283","article-title":"Thalidomide: an unfinished history.","volume":"78","author":"E Papaseit","year":"2013","journal-title":"An Pediatr (Barc)."},{"key":"pntd.0008329.ref003","unstructured":"Vianna FSL. Talidomida no Brasil: Vigil\u00e2ncia Epidemiol\u00f3gica, Teratog\u00eanese e Farmacogen\u00e9tica [D. Sc. Thesis]. Porto Alegre: Federal University of Rio Grande do Sul; 2013. Available from: https:\/\/sucupira.capes.gov.br\/sucupira\/public\/consultas\/coleta\/trabalhoConclusao\/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=401092"},{"key":"pntd.0008329.ref004","unstructured":"Santos FL. A Hist\u00f3ria da Talidomida no Brasil e a trajet\u00f3ria para conquista de direitos das pessoas com a S\u00edndrome Teratog\u00eanica [M. Sc. Dissertation]. Ponta Grossa: State University of Ponta Grossa; 2018. https:\/\/sucupira.capes.gov.br\/sucupira\/public\/consultas\/coleta\/trabalhoConclusao\/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=6384077"},{"issue":"2","key":"pntd.0008329.ref005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/bdrc.21096","article-title":"Thalidomide\u2010induced teratogenesis: History and mechanisms.","volume":"105","author":"N Vargesson","year":"2015","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"12","key":"pntd.0008329.ref006","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/bies.200900103","article-title":"Thalidomide\u2010induced limb defects: resolving 50-year-old puzzle","volume":"31","author":"N Vargesson","year":"2009","journal-title":"Bioessays"},{"issue":"3","key":"pntd.0008329.ref007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1096-8628(19971219)73:3<251::AID-AJMG4>3.0.CO;2-V","article-title":"The Return of Thalidomide: Are Birth Defects Surveillance Systems Ready?","volume":"73","author":"Q Yang","year":"1997","journal-title":"Am J Med Genet"},{"issue":"9","key":"pntd.0008329.ref008","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/bdra.23376","article-title":"Thalidomide Embryopathy: Follow-Up of Cases Born between 1959 and 2010.","volume":"103","author":"TW Kowalski","year":"2015","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"6","key":"pntd.0008329.ref009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#","article-title":"Thalidomide, a Current Teratogen in South America","volume":"54","author":"EE Castilla","year":"1996","journal-title":"Teratology"},{"key":"pntd.0008329.ref010","unstructured":"Moro A. Participa\u00e7\u00e3o Social e Regula\u00e7\u00e3o de Medicamentos: o Caso da Talidomida no Brasil [D. Sc. Thesis]. Curitiba: Federal University of Paran\u00e1; 2017. Available from: https:\/\/sucupira.capes.gov.br\/sucupira\/public\/consultas\/coleta\/trabalhoConclusao\/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=5110191"},{"key":"pntd.0008329.ref011","article-title":"Estudio sobre La utilizaci\u00f3n de la talidomida desde los tr\u00e1gicos a\u00f1os sesenta hasta la actualidad: An\u00e1lisis desde la perspectiva legal y \u00e9tica.","author":"CR Bosch","year":"2012","journal-title":"Pharmacist, University of Barcelona."},{"issue":"4","key":"pntd.0008329.ref012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00002018-200629040-00003","article-title":"Thalidomide use in the US: experience with pregnancy testing in the S.T.E.P.S. programme.","volume":"29","author":"K Uhl","year":"2006","journal-title":"Drug Saf."},{"issue":"4","key":"pntd.0008329.ref013","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40264-016-0501-2","article-title":"Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention.","volume":"40","author":"NA Brandenburg","year":"2017","journal-title":"Drug Saf. England"},{"issue":"1","key":"pntd.0008329.ref014","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11318920-000000000-00000","article-title":"Resolving a Double Standard for Risk Management of Thalidomide: An Evaluation of Two Different Risk Management Programmes in Japan.","volume":"33","author":"N Ooba","year":"2010","journal-title":"Drug Saf."},{"issue":"4","key":"pntd.0008329.ref015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14740338.2014.887678","article-title":"A comparison of pregnancy prevention programmes in Europe.","volume":"13","author":"I Crijns","year":"2014","journal-title":"Straus S.Expert Opin Drug Saf."},{"key":"pntd.0008329.ref016","unstructured":"Brasil. Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Resolu\u00e7\u00e3o da Diretoria Colegiada n\u00ba 50, de 11 de novembro de 2015. Disp\u00f5e sobre a atualiza\u00e7\u00e3o do Anexo III, Indica\u00e7\u00f5es previstas para tratamento com a Talidomida, da RDC n\u00ba 11, de 22 de mar\u00e7o de 2011. Bras\u00edlia, 12 nov. 2015. [cited 2018 Oct 14]. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/anvisa\/2015\/rdc0050_11_11_2015.pdf"},{"key":"pntd.0008329.ref017","unstructured":"Brasil. Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Resolu\u00e7\u00e3o da Diretoria Colegiada n\u00ba 11, de 22 de mar\u00e7o de 2011. Disp\u00f5e o controle da subst\u00e2ncia Talidomida e do medicamento que a contenha. Bras\u00edlia, 09 mai. 2011. [cited 2018 Oct 14]. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/anvisa\/2015\/rdc0050_11_11_2015.pdf"},{"key":"pntd.0008329.ref018","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Diretrizes para vigil\u00e2ncia, aten\u00e7\u00e3o e elimina\u00e7\u00e3o da Hansen\u00edase como problema de sa\u00fade p\u00fablica: manual t\u00e9cnico-operacional. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2016. 58 p."},{"key":"pntd.0008329.ref019","first-page":"36","volume-title":"Estrat\u00e9gia Global para Hansen\u00edase 2016\u20132020: Acelera\u00e7\u00e3o rumo a um mundo sem hansen\u00edase","author":"World Health Organization","year":"2016"},{"key":"pntd.0008329.ref020","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Guia Pr\u00e1tico sobre a hansen\u00edase. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2017. 68 p."},{"issue":"69","key":"pntd.0008329.ref021","first-page":"2010","article-title":"Scoping studies: advancing the methodology.","volume":"5","author":"D Levac","year":"2010","journal-title":"Implementation Science"},{"issue":"7","key":"pntd.0008329.ref022","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"5","key":"pntd.0008329.ref023","first-page":"511","article-title":"Thalidomide in the treatment of erythema nodosum leprosum (ENL): systematic review of clinical trials and prospects of new investigations.","volume":"80","author":"GO Penna","year":"2005","journal-title":"An Bras Dermatol"},{"issue":"3","key":"pntd.0008329.ref024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00002018-199921030-00002","article-title":"The return of thalidomide: can birth defects be prevented?","volume":"21","author":"JM Lary","year":"1999","journal-title":"Drug Saf"},{"key":"pntd.0008329.ref025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actatropica.2018.02.026","article-title":"Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.","volume":"183","author":"PDSS Costa","year":"2018","journal-title":"Acta Trop."},{"issue":"4","key":"pntd.0008329.ref026","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/pd.1970070411","article-title":"Prenatal diagnosis of thalidomide syndrome.","volume":"7","author":"TR Gollop","year":"1987","journal-title":"Prenat Diagn."},{"issue":"8904","key":"pntd.0008329.ref027","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(94)90163-5","article-title":"Thalidomide: 35 years on and still deforming.","volume":"343","author":"GR Jones","year":"1994","journal-title":"Lancet."},{"issue":"9","key":"pntd.0008329.ref028","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/bdra.20384","article-title":"New Cases of Thalidomide Embryopathy in Brazil.","volume":"79","author":"L Schuler-Faccini","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"7","key":"pntd.0008329.ref029","doi-asserted-by":"crossref","first-page":"e21735","DOI":"10.1371\/journal.pone.0021735","article-title":"Epidemiological Surveillance of Birth Defects Compatible with Thalidomide Embryopathy in Brazil.","volume":"6","author":"FSL Vianna","year":"2011","journal-title":"PLoS ONE."},{"key":"pntd.0008329.ref030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.reprotox.2015.03.007","article-title":"Pharmacoepidemiology and thalidomide embryopathy surveillance in Brazil.","volume":"53","author":"FSL Vianna","year":"2015","journal-title":"Reprod Toxicol."},{"issue":"2","key":"pntd.0008329.ref031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MCD.0b013e32835ffc58","article-title":"Recognition of the phenotype of thalidomide embryopathy in countries endemic for leprosy: new cases and review of the main dysmorphological findings.","volume":"22","author":"FSL Vianna","year":"2013","journal-title":"Clin Dysmorphol."},{"issue":"8900","key":"pntd.0008329.ref032","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(94)91874-0","article-title":"Thalidomide revisited","volume":"343","author":"J. Cutler","year":"1994","journal-title":"Lancet."},{"issue":"1","key":"pntd.0008329.ref033","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0037-86822003000100009","article-title":"Perfil dos pacientes com hansen\u00edase em \u00e1rea hiperend\u00eamica da Amaz\u00f4nia do Maranh\u00e3o, Brasil.","volume":"36","author":"DMC Aquino","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"pntd.0008329.ref034","article-title":"Perfil socioecon\u00f4mico e demogr\u00e1fico de portadores de hansen\u00edase atendidos em consulta de enfermagem.","author":"MTC Duarte","year":"2007","journal-title":"Rev Latino-Am Enfermagem"},{"issue":"1","key":"pntd.0008329.ref035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/S0034-89102011005000086","article-title":"Spatial analysis of leprosy incidence and associated socioeconomic factors.","volume":"46","author":"Paschoal VD Cury MRCO","year":"2012","journal-title":"Rev Sa\u00fade P\u00fablica"},{"issue":"9","key":"pntd.0008329.ref036","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1590\/S1413-81232012000900033","article-title":"Pacientes em centro de refer\u00eancia para Hansen\u00edase: Rio de Janeiro e Duque de Caxias, 1986\u20132008.","volume":"17","author":"Sales AM Hacker MAVB","year":"2012","journal-title":"Ci\u00eanc sa\u00fade coletiva"},{"issue":"103","key":"pntd.0008329.ref037","first-page":"817","article-title":"Hansen\u00edase e vulnerabilidade social: uma an\u00e1lise do perfil socioecon\u00f4mico de usu\u00e1rios em tratamento irregular.","volume":"38","author":"VAS Lopes","year":"2014","journal-title":"Sa\u00fade debate"},{"issue":"1","key":"pntd.0008329.ref038","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/S1414-81452011000100009","article-title":"Perfil epidemiol\u00f3gico da hansen\u00edase na microrregi\u00e3o de Ara\u00e7ua\u00ed e sua rela\u00e7\u00e3o com a\u00e7\u00f5es de controle.","volume":"15","author":"FCF Lana","year":"2011","journal-title":"Esc Anna Nery"},{"issue":"4","key":"pntd.0008329.ref039","doi-asserted-by":"crossref","first-page":"817","DOI":"10.5123\/S1679-49742017000400013","article-title":"Avalia\u00e7\u00e3o da implanta\u00e7\u00e3o do Programa de Controle da Hansen\u00edase em Camaragibe, Pernambuco.","volume":"26","author":"MF Souza","year":"2017","journal-title":"Epidemiol Serv Sa\u00fade"},{"issue":"112","key":"pntd.0008329.ref040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1590\/0103-1104201711219","article-title":"Hansen\u00edase e Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade: uma avalia\u00e7\u00e3o de estrutura do programa.","volume":"41","author":"GS Sousa","year":"2017","journal-title":"Sa\u00fade debate"},{"key":"pntd.0008329.ref041","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1590\/S0034-71672008000700011","article-title":"Aten\u00e7\u00e3o b\u00e1sica de sa\u00fade e a assist\u00eancia em Hansen\u00edase em servi\u00e7os de sa\u00fade de um munic\u00edpio do Estado de S\u00e3o Paulo.","volume":"61","author":"AJ Pereira","year":"2008","journal-title":"Rev Bras Enferm"},{"key":"pntd.0008329.ref042","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Ci\u00eancia, Tecnologia e Insumos Estrat\u00e9gicos. Rela\u00e7\u00e3o Nacional de Medicamentos Essenciais 2018. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2018. 218 p."},{"key":"pntd.0008329.ref043","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Talidomida: orienta\u00e7\u00e3o para o uso controlado. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2014. 100 p."},{"key":"pntd.0008329.ref044","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Pol\u00edtica Nacional de Aten\u00e7\u00e3o B\u00e1sica. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2012. 110 p."},{"key":"pntd.0008329.ref045","unstructured":"World Health Organization. Global leprosy update, 2017: reducing the disease burden due to leprosy. Weekly Epidemiological Record [Internet]. 2018 [cited 2019 Apr 14];93(35): 445\u2013456. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274289\/WER9335.pdf?ua=1"},{"key":"pntd.0008329.ref046","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Portaria n\u00ba 354, de 15 de agosto de 1997. Regulamentar o registro, a produ\u00e7\u00e3o, a fabrica\u00e7\u00e3o, a comercializa\u00e7\u00e3o, a exposi\u00e7\u00e3o \u00e0 venda, a prescri\u00e7\u00e3o e a dispensa\u00e7\u00e3o dos produtos \u00e0 base de talidomida. Di\u00e1rio Oficial da Uni\u00e3o, Bras\u00edlia, 18 ago. 1997."},{"key":"pntd.0008329.ref047","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Portaria n\u00ba 344, de 12 de maio de 1998. Aprova o Regulamento T\u00e9cnico sobre subst\u00e2ncias e medicamentos sujeitos a controle especial. Di\u00e1rio Oficial da Uni\u00e3o, Bras\u00edlia, 31 dez. 1998. [cited 2019 Oct 14]. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/svs\/1998\/prt0344_12_05_1998_rep.html"},{"key":"pntd.0008329.ref048","unstructured":"Brasil. Presid\u00eancia da Rep\u00fablica. Lei n\u00ba 10.651, de 16 de abril de 2003. Disp\u00f5e sobre o controle do uso da talidomida. Bras\u00edlia, 17 abr. 2003. [cited 2019 Oct 14]. Available from: http:\/\/www.planalto.gov.br\/ccivil_03\/Leis\/2003\/L10.651.htm"},{"key":"pntd.0008329.ref049","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Portaria de Consolida\u00e7\u00e3o n\u00ba 2, de 28 de setembro e 2017. Consolida\u00e7\u00e3o das normas das pol\u00edticas nacionais de sa\u00fade do Sistema \u00danico de Sa\u00fade. Di\u00e1rio Oficial da Uni\u00e3o, Bras\u00edlia, 03 dec. 2017. [cited 2019 Oct 14]. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/2017\/prc0002_03_10_2017.html"},{"key":"pntd.0008329.ref050","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Portaria de Consolida\u00e7\u00e3o n\u00ba 6, de 28 de setembro de 2017. Consolida\u00e7\u00e3o das normas das pol\u00edticas nacionais de sa\u00fade do Sistema \u00danico de Sa\u00fade. Di\u00e1rio Oficial da Uni\u00e3o, Bras\u00edlia, 03 dec. 2017. [cited 2019 Oct 14]. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/2017\/prc0006_03_10_2017.html"},{"key":"pntd.0008329.ref051","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Portaria n\u00ba 100, de 7 de fevereiro de 2013. Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas do L\u00fapus Eritematoso Sist\u00eamico. Di\u00e1rio Oficial da Uni\u00e3o, Bras\u00edlia, 02 feb. 2013. [cited 2019 Oct 14]. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/sas\/2013\/prt0100_07_02_2013.html"},{"key":"pntd.0008329.ref052","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Portaria n\u00ba 298 de 21 de mar\u00e7o de 2013. Atualiza os protocolos de uso da Talidomida no tratamento da Doen\u00e7a Enxerto Contra Hospedeiro e do Mieloma M\u00faltiplo. Di\u00e1rio Oficial da Uni\u00e3o, Bras\u00edlia, 22 mar. 2013. [cited 2019 Oct 14]. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/sas\/2013\/prt0298_21_03_2013.html"},{"key":"pntd.0008329.ref053","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Portaria n\u00ba 493, de 11 de junho de 2015. Aprova o Protocolo de uso da talidomida no tratamento da s\u00edndrome mielodispl\u00e1sica. Di\u00e1rio Oficial da Uni\u00e3o, Bras\u00edlia, 12 jun. 2015b. [cited 2019 Oct 14]. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/sas\/2015\/prt0493_11_06_2015.html"},{"key":"pntd.0008329.ref054","unstructured":"Brasil. Presid\u00eancia da Rep\u00fablica. Lei n\u00ba 12.401, de 28 de abril de 2011. Altera a Lei no 8.080, de 19 de setembro de 1990, para dispor sobre a assist\u00eancia terap\u00eautica e a incorpora\u00e7\u00e3o de tecnologia em sa\u00fade no \u00e2mbito do Sistema \u00danico de Sa\u00fade\u2014SUS. Bras\u00edlia, 29 abr. 2011. [cited 2019 Oct 14]. Available from: http:\/\/www.planalto.gov.br\/ccivil_03\/_Ato2011-2014\/2011\/Lei\/L12401.htm"},{"key":"pntd.0008329.ref055","unstructured":"Brasil. Presid\u00eancia da Rep\u00fablica. Decreto n\u00ba 7.508, de 28 de junho de 2011.Regulamenta a Lei no 8.080, de 19 de setembro de 1990, para dispor sobre a organiza\u00e7\u00e3o do Sistema \u00danico de Sa\u00fade - SUS, o planejamento da sa\u00fade, a assist\u00eancia \u00e0 sa\u00fade e a articula\u00e7\u00e3o interfederativa, e d\u00e1 outras provid\u00eancias. Bras\u00edlia, 29 jun. 2011. [cited 2019 Oct 14]. Available from: http:\/\/www.planalto.gov.br\/ccivil_03\/_ato2011-2014\/2011\/decreto\/d7508.htm"},{"key":"pntd.0008329.ref056","unstructured":"Brasil. Presid\u00eancia da Rep\u00fablica. Lei n\u00ba 7.070, de 20 de dezembro de 1982. Disp\u00f5e sobre pens\u00e3o especial para os deficientes f\u00edsicos que especifica e d\u00e1 outras providencias. Bras\u00edlia, 21 dez. 1982. [cited 2019 Oct 14]. Available from: http:\/\/www.planalto.gov.br\/ccivil_03\/leis\/1980-1988\/L7070.htm"},{"key":"pntd.0008329.ref057","unstructured":"Brasil. Presid\u00eancia da Rep\u00fablica. Lei n\u00ba 12.190, de 13 de janeiro de 2010. Concede indeniza\u00e7\u00e3o por dano moral \u00e0s pessoas com defici\u00eancia f\u00edsica decorrente do uso da talidomida, altera a Lei no 7.070, de 20 de dezembro de 1982, e d\u00e1 outras provid\u00eancias. Bras\u00edlia, 13 jan. 2010. [cited 2019 Oct 14]. Available from: http:\/\/www.planalto.gov.br\/ccivil_03\/_Ato2007-2010\/2010\/Lei\/L12190.htm"},{"key":"pntd.0008329.ref058","unstructured":"Brasil. Controladoria-Geral da Uni\u00e3o. Sistema Eletr\u00f4nico do Servi\u00e7o de Informa\u00e7\u00f5es ao Cidad\u00e3o. Informa\u00e7\u00f5es sobre aquisi\u00e7\u00e3o, distribui\u00e7\u00e3o e casos de talidomida no Brasil [Internet]. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade. 2019 [cited 2019 May 07]. Available from: https:\/\/esic.cgu.gov.br\/sistema\/site\/index.aspx"},{"key":"pntd.0008329.ref059","unstructured":"SINAN: Sistema de Informa\u00e7\u00e3o de Agravos de Notifica\u00e7\u00e3o. Hansen\u00edase [Internet]. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade. 2017 [cited 2019 Apr 22]. Available from: http:\/\/tabnet.datasus.gov.br\/cgi\/dhdat.exe?ETL_hanseniase\/ETL_hantfbr17.def"},{"key":"pntd.0008329.ref060","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Anvisa realiza treinamento sobre uso da talidomida [Internet]. Bras\u00edlia: Anvisa; 2011 May 26 [cited 2019 Apr 14]. Available from: http:\/\/www.brasil.gov.br\/noticias\/saude\/2011\/05\/anvisa-realiza-treinamento-sobre-uso-da-talidomida"},{"key":"pntd.0008329.ref061","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Agenda de treinamentos [Internet]. Bras\u00edlia: Anvisa; 2011 [cited 2019 Apr 14]. Available from: http:\/\/talidomida-anvisa.blogspot.com\/p\/agenda-de-treinamentos.html"},{"key":"pntd.0008329.ref062","unstructured":"Minist\u00e9rio da Sa\u00fade. I Encontro Nacional sobre o Controle da Talidomida [Internet]. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2016 [cited 2019 Apr 14]. Available from: http:\/\/portalms.saude.gov.br\/assistencia-farmaceutica\/medicamentos-rename\/cesaf\/43993-talidomida"},{"key":"pntd.0008329.ref063","unstructured":"Estimativas da Popula\u00e7\u00e3o [Internet]. Rio de Janeiro: IBGE. 2018 [cited 2019 Apr 14]. Available from: https:\/\/www.ibge.gov.br\/estatisticas\/sociais\/populacao\/9103-estimativas-de-populacao.html?edicao=17283&t=downloads"},{"issue":"10","key":"pntd.0008329.ref064","doi-asserted-by":"crossref","first-page":"e0204723","DOI":"10.1371\/journal.pone.0204723","article-title":"The different clinical guideline standards in Brazil: High cost treatment diseases versus poverty-related diseases","volume":"13","author":"RS Santana","year":"2018","journal-title":"PLoS ONE"},{"key":"pntd.0008329.ref065","unstructured":"World Health Organization. Use of Thalidomide in Leprosy [Internet]. Genebra: WHO. [cited 2019 Apr 14]. Available from: www.who.int\/lep\/research\/thalidomide\/en\/."},{"key":"pntd.0008329.ref066","unstructured":"Esher A, Santos EM, Luiza VL. Monitoramento e Avalia\u00e7\u00e3o. In: Osorio-de-Castro CGS, Luiza VL, Castilho SR, Oliveira MA, Jaramillo NM (org.). Assist\u00eancia Farmac\u00eautica: Gest\u00e3o e Pr\u00e1tica para profissionais de sa\u00fade. 1. ed. Rio de Janeiro: Fiocruz, 2014.p. 163\u2013174."},{"key":"pntd.0008329.ref067","first-page":"253","volume-title":"Sistemas de Informa\u00e7\u00e3o em Sa\u00fade.","author":"CM Coeli","year":"2014","edition":"1"},{"issue":"Suppl2","key":"pntd.0008329.ref068","first-page":"12s","article-title":"Situa\u00e7\u00e3o sanit\u00e1ria dos medicamentos na aten\u00e7\u00e3o b\u00e1sica no Sistema \u00danico de Sa\u00fade.","volume":"51","author":"EA Costa","year":"2017","journal-title":"Rev Sa\u00fade P\u00fablica"},{"issue":"Suppl 2","key":"pntd.0008329.ref069","first-page":"2s","article-title":"Perfil do acesso e da utiliza\u00e7\u00e3o de medicamentos da popula\u00e7\u00e3o brasileira\u2013contribui\u00e7\u00f5es e desafios da PNAUM\u2013Inqu\u00e9rito Domiciliar.","volume":"50","author":"JAZ Bermudez","year":"2016","journal-title":"Rev. Sa\u00fade P\u00fablica"},{"issue":"Suppl 2","key":"pntd.0008329.ref070","first-page":"13s","article-title":"Infraestrutura das farm\u00e1cias da aten\u00e7\u00e3o b\u00e1sica no Sistema \u00danico de Sa\u00fade: An\u00e1lise dos dados da PNAUM-Servi\u00e7os.","volume":"51","author":"SN Leite","year":"2017","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"pntd.0008329.ref071","first-page":"115","volume-title":"Contexto Sociocultural do Uso de Medicamentos","author":"EE Diehl","year":"2016"},{"issue":"Suppl2","key":"pntd.0008329.ref072","first-page":"13s","article-title":"Preval\u00eancia da automedica\u00e7\u00e3o no Brasil e fatores associados.","volume":"50","author":"PSD Arrais","year":"2016","journal-title":"Rev. Sa\u00fade P\u00fablicaInternet]"},{"key":"pntd.0008329.ref073","unstructured":"Pan American Health Organization. OPAS\/OMS apresenta estrat\u00e9gia global e projeto para livrar Brasil da hansen\u00edase [Internet]. Bras\u00edlia: OPAS. 2017 Oct 20 [cited 2019 Apr 14]. Available from: https:\/\/www.paho.org\/bra\/index.php?option=com_content&view=article&id=5531:opas-oms-apresenta-estrategia-global-e-projeto-para-livrar-brasil-da-hanseniase&Itemid=812"},{"key":"pntd.0008329.ref074","first-page":"197","volume-title":"Conselho Nacional de Secret\u00e1rios de Sa\u00fade. CONASS. Aten\u00e7\u00e3o Prim\u00e1ria e Promo\u00e7\u00e3o da Sa\u00fade","year":"2011"},{"issue":"2","key":"pntd.0008329.ref075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5123\/S1679-49742017000200005","article-title":"Censo de estrutura da Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade no Brasil (2012): estimativas de coberturas potenciais.","volume":"26","author":"KC Po\u00e7as","year":"2017","journal-title":"Epidemiol Serv Sa\u00fade"},{"issue":"103","key":"pntd.0008329.ref076","first-page":"756","article-title":"Produ\u00e7\u00e3o e registro de informa\u00e7\u00f5es em sa\u00fade no Brasil: panorama descritivo atrav\u00e9s do PMAQ-AB","volume":"38","author":"TCCL Neves","year":"2014","journal-title":"Sa\u00fade debate"},{"key":"pntd.0008329.ref077","article-title":"Disponibilidade de medicamentos nas unidades b\u00e1sicas de sa\u00fade e fatores relacionados: uma abordagem transversal.","author":"LV Mendes","year":"2014","journal-title":"Sa\u00fade debate"},{"issue":"9","key":"pntd.0008329.ref078","doi-asserted-by":"crossref","first-page":"PE1226","DOI":"10.1016\/S2214-109X(19)30260-8","article-title":"Socioeconomic determinants of leprosy new case detection in the 100 Million Brazilian Cohort: a population-based linkage study","volume":"7","author":"JS Nery","year":"2019","journal-title":"Lancet Global Health"},{"issue":"5","key":"pntd.0008329.ref079","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1590\/1413-81232017225.32762016","article-title":"Registro e incorpora\u00e7\u00e3o de tecnologias no SUS: barreiras de acesso a medicamentos para doen\u00e7as da pobreza?.","volume":"22","author":"RS Santana","year":"2017","journal-title":"Ci\u00eanc. sa\u00fade coletiva"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T17:39:27Z","timestamp":1596735567000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008329"}},"subtitle":[],"editor":[{"given":"Bruce Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":79,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008329","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]}}}